Sign in
Taking peopleNo phase

Delirium Treatment With Transcranial Electrical Stimulation

Key facts

Who runs it
A.J.C. Slooter
Where
Netherlands2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
159 people, planned
Started
24 Apr 2024
Expected to end
31 Mar 2027
Type of study
Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • transcranial alternating current stimulation (tACS)
  • Sham transcranial alternating current stimulation (tACS)
Record updated
26 July 2024

Who can take part

Age
50 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age over 50 years
  • Diagnosis of delirium
  • Richmond Agitation and Sedation Scale (RASS) score of -2 to +2
  • Delirium duration of at least two days prior to study inclusion, based delirium assessments and/or descriptions in the medical and/or nursing files
  • Known causes underlying delirium are being treated adequately, as assessed by the treating physician

Who cannot take part

  • Alcohol/substance abuse withdrawal or stroke as precipitating factor for delirium
  • Diagnosis of dementia, based on medical record review and/or a score of ≥4.5 on the short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
  • One or more contra-indications for tACS:; History of serious head trauma or brain surgery; Large or ferromagnetic metal parts in the head (except for a dental wire); Implanted cardiac pacemaker or neurostimulator; Skin diseases or inflammations; Epilepsy
  • Inability to conduct delirium assessment (e.g. coma, deaf, blind) or inability to speak Dutch or English
  • A moribund state

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to investigate the effectiveness of standardized and personalized transcranial alternating current stimulation (tACS) in patients with delirium. To investigate this, will perform a double-blind, randomized, sham-controlled, multicenter trial.

Read full original descriptionShow less

To test the safety and feasibility of tACS in delirious patients, the first 30 patients will be randomized to receive either active or sham tACS treatment in a 1:1 ratio through a pilot study. For the main phase of the study, patients will be randomized, resulting in an overall 1:1:1 allocation to standardized tACS, personalized tACS or sham treatment.

Electroencephalogram (EEG) will be measured directly before and directly after the first stimulation session to assess whether tACS can reduce relative delta power. tACS or sham treatment will be given once daily for a maximum of 14 days, or until resolution of delirium or discharge (whichever comes first). During the treatment phase, presence and severity of delirium will be assessed daily. After the treatment phase, an additional EEG will be measured. Cognitive status will be assessed three months after the initial tACS session.

The 3 groups in the trial

  • Standardized treatment armTreatment being tested

    Standardized tACS will be applied with 2.0 mA (peak-to-peak) intensity for 30 minutes, with a 10 Hz frequency. Two 5x5 cm saline-soaked electrodes located at the frontal and occipito-parietal part of the scalp will be utilized (corresponding to 10-20 EEG electrode locations POz-Oz and AFz), including in the stimulation field the DLPFC, precuneus and posterior cingulate cortex. At the beginning of stimulation, the intensity will ramp up for 30 seconds to 2.0 mA peak-to-peak, while at the end of stimulation, the intensity will ramp down for 30 seconds.

    Treatment: transcranial alternating current stimulation (tACS)

  • Personalized treatment armTreatment being tested

    Personalized tACS will be applied with 2.0 mA (peak-to-peak) intensity for 30 minutes with a 30 second ramp up and ramp down. Treatment will be personalized based on a delirium neural mass model. After fitting the model to the individual EEG, a virtual tACS trial allows for optimization of treatment parameters for each individual patient. Treatment optimization will take place through changing stimulation location and/or frequency. After determining the optimal individual treatment strategy, settings of the personalized stimulation will remain constant during the treatment phase.

    Treatment: transcranial alternating current stimulation (tACS)

  • Sham treatment armSham treatment, for comparison

    At the beginning and end of this 30-minute protocol, the tACS device will ramp up to 2.0 mA peak-to-peak intensity for 30 seconds, stimulate for 60 seconds and ramp down for 30 seconds, which mimics the sensation of actual tACS stimulation and improves blinding.

    Treatment: Sham transcranial alternating current stimulation (tACS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
DELirium Treatment With Transcranial Electrical Stimulation
Publications
Record updated
26 July 2024